首次出版：最新修訂：March 2009交付方式：特快專遞(2-3天送達)
報告屬性：共151頁下載目錄 版權(quán)聲明
定購電話：0755-82571522、82571566、400-008-1522
24小時服務(wù)熱線：138 0270 8576 定制報告
| 版本 | 在線版 | 電子版+印刷版 | 在線報告庫（超1000份報告）全庫 |
|---|---|---|---|
| 優(yōu)惠價 | RMB 6800 | RMB 7800 | RMB 9800 |
| 原價 | RMB 9600 | RMB 9800 | - |
聯(lián)系電話： 400 008 0586; 0755-82571568
微信掃碼： 
Chapter1
ExecutiveSummary
Introduction1-1
U.S.SyringesandNeedlesMarket1-1
Chapter2
TotalU.S.SyringesandNeedlesMarket
MarketOverview2-1
Introduction2-1
ResearchMethodology2-2
ProjectCommencement2-2
SecondaryResearch2-2
ResearchInstruments2-3
SamplingPlan2-3
DevelopmentofDatabaseofKeyIndustryParticipants‘2-3
PrimaryResearch2-3
Cross-verificationofData2-4
'Bottom-up'Approach2-4
'Bottom-up'versus'Top-down'Approach2-4
Expert-opinionConsensusForecastingModel2-5
ScopeandSegmentation2-5
ComparisontoPreviousResearch2-6
MarketDynamics2-6
TotalMarketDrivers2-6
FavorableDemographicsHighlightNeedforAvailabilityofInjectionDevices2-7
AlternateCareFacilitiesProvideNewMarketforDevices2-7
ProhibitiveCostofNeedle-freeDevicesEnablesConventionalMarketstoFlourish2-8
IncreasedPatientAwarenessofDiagnosticOptionsSpursNeedleandSyringeUse2-8
HighDependencyonSteelandPlasticsMarketsPreventsSignificantPriceErosion2-8
SafetyDeviceSpecificMarketDrivers2-8
Passageof2000NeedlestickSafetyandPreventionActProdsPurchaseofSaferAlternatives2-9
AdditionalSafetyLegislationbyStatesForcesAdoptionofSafetyDevices2-10
PressurebyHealthcareWorkerUnionsandOrganizationsStimulatesPurchaseofSafetyDevicesbyEmployers2-10
AwarenessofCostsofExposureEncouragesProactiveSpendingonSafetyDevices2-10
TechnologyAdvancementinSafetyDevicesSpacePromotesManufactureandSale2-11
TraditionalDeviceSpecificMarketDriver2-11
DecriminalizationofNeedlePossessionCreatesMarketatStateLevel2-11
TotalMarketRestraints2-12
PressureonHospitalstoContainCostsLowersRevenues2-12
NeedforNeedle-freeSystemsCapturesMarketfromTraditionalNeedleandSyringeApplications2-12
SafetyDeviceSpecificMarketRestraints2-13
HighCostRelativetoTraditionalCounterpartsDiscouragesAdoption2-13
LackofEducationforHealthcareWorkersHindersAdoption2-14
LackofEnforcementandAccountabilityDissuadesAdoptionofSafetyDevices2-14
NeedtoExhaustExistingStockpilesofTraditionalDevicesLimitsDesireforSafetyDevices2-15
AdditionalCostofManufacturingSaferDevicesHindersProductionRefocus2-15
MarketEngineeringMeasurements2-15
MarketForecastsandTrends2-17
RevenueForecasts2-17
UnitForecasts2-21
CompetitiveAnalysis2-25
CompetitiveStructure2-25
CompetitiveFactors2-27
BrandAwareness2-27
TechnologicalInnovation2-28
ProductAcceptance2-28
MarketShareAnalysis2-28
DatabaseofKeyIndustryParticipants2-30
DistributionStructure2-32
ChallengesandRecommendations2-32
IndustryChallenges2-32
EstablishedMarketParticipantsCauseDifficultyforNewerEntrantstoBoostMarketShare2-33
CompanieswithDedicatedResourcesforProducing
TraditionalDevicesHaveDifficultyEnteringSafetyMarket2-33
StrategicRecommendations2-33
LeverageProductLinetoTargetNon-GPOMarkets2-34
ExpandandLeverageTraditionalProductLinestoExemplifySuperiority2-34
Chapter3
BloodCollectionSyringesandNeedlesMarket
Overview3-1
MarketOverview3-1
TechnologyAnalysis3-2
MarketDynamics3-2
MarketDriver3-2
CriticalNeedforWorkerProtectionBoostsBloodCollectionSafetyDeviceUptake3-2
MarketEngineeringMeasurements3-3
MarketForecastsandTrends3-4
RevenueForecasts3-4
UnitForecasts3-8
CompetitiveAnalysis3-12
CompetitiveStructure3-12
MarketShareAnalysis3-13
ProductAnalysis3-15
Chapter4
HypodermicSyringesandNeedlesMarket
Overview4-1
MarketOverview4-1
TechnologyAnalysis4-1
MarketDynamics4-2
MarketDriver4-2
TechnologyInnovationBoostsSafetyHypodermicDeviceSpace4-2
MarketEngineeringMeasurements4-3
MarketForecastsandTrends4-4
RevenueForecasts4-4
UnitForecasts4-8
CompetitiveAnalysis4-12
CompetitiveStructure4-12
MarketShareAnalysis4-14
ProductAnalysis4-16
Chapter5
InsulinSyringesandNeedlesMarket
Overview5-1
MarketOverview5-1
MarketDynamics5-2
MarketDrivers5-2
SlowAdvancementinAlternativeInsulinDeliverySpaceSustainsSyringesandNeedlesMarket5-2
ProvenEfficacyofInsulinSyringesDrivesSelectionofDevice5-3
LowPricePointPreventsSwitchtoAlternativeDeliveryOptions5-3
TechnologyAdvancementMaintainsCustomerBase5-3
MarketRestraints5-4
Self-injectionHindersSafetyInsulinSyringesMarket5-4
AversiontoNeedlesEncouragesUseofAlternativeDevices5-5
DecreasingPriceGapLeadstoGrowthofInsulinPensMarket5-5
MarketEngineeringMeasurements5-5
MarketForecastsandTrends5-7
RevenueForecasts5-7
UnitForecasts5-10
CompetitiveAnalysis5-14
CompetitiveStructure5-14
MarketShareAnalysis5-15
ProductAnalysis5-17
Chapter6
PortAccessNeedlesMarket
Overview6-1
MarketOverview6-1
TechnologyAnalysis6-1
MarketDynamics6-2
MarketRestraint6-2
MarketShifttowardNeedle-freeDevicesHindersGrowthofStandardPortAccessProducts6-2
MarketEngineeringMeasurements6-3
MarketForecastsandTrends6-4
RevenueForecasts6-4
UnitForecasts6-8
CompetitiveAnalysis6-12
CompetitiveStructure6-12
MarketShareAnalysis6-13
ProductAnalysis6-15
Chapter7
OtherSpecialtySyringesandNeedlesMarket
Overview7-1
MarketOverview7-1
MarketDynamics7-1
MarketEngineeringMeasurements7-1
MarketForecastsandTrends7-3
RevenueForecasts7-3
UnitForecasts7-6
CompetitiveAnalysis7-9
CompetitiveStructure7-9
MarketShareAnalysis7-10
Chapter8
Appendix
DecisionSupportDatabase8-1
TotalHealthcareExpenditure8-1
NumberofHospitals8-3
NumberofNurses8-5
NumberofPhysicians8-8
IncidenceofDiabetes8-10
Exposure to bloodborne pathogens due to accidental needlestick injuries or splashing of body fluids is the greatest problem faced by health care workers. Despite the relative safety of the modern health care setting, physicians, nurses, and other frontline care providers who directly interact with patients are exposed to serious and potentially deadly conditions, including hepatitis B, HIV, and tuberculosis. A proactive method to counteract the incidence
of sharps injury is the use of approved safety needles and syringes, as outlined by the OSHA Bloodborne Pathogens Standard of 1991 and revised by the Needlestick Safety and Prevention Act of 2000. Prior to the approval of such legislation, up to an estimated 600,000 workers came into contact with contaminated blood or other body fluids due to a sharps injury, on an annual basis. Although no device that comes into contact with a patient’s body fluids provides perfect protection, the use of Food and Drug Administrationapproved safety devices is a step toward mitigating the risks to which health care workers are susceptible.
外商投資企業(yè)協(xié)會會員單位
最具品牌價值行業(yè)門戶
發(fā)改委十佳創(chuàng)新案例金典獎
電子行業(yè)協(xié)會副會長單位
哈爾濱最佳項目策劃智庫單位
深圳市商業(yè)聯(lián)合會會員單位
珠海招商合伙人
重慶市產(chǎn)業(yè)招商聯(lián)盟單位
中投顧問協(xié)辦的濟陽區(qū)（深圳） "新能源汽車產(chǎn)業(yè)"專題推介會
中投顧問受邀為合肥市投促部門作機器人產(chǎn)業(yè)招商培訓(xùn)
中投顧問為珠海全市招商系統(tǒng)培訓(xùn)產(chǎn)業(yè)招商大腦獲得圓滿成功
中投顧問為漢中市作"大數(shù)據(jù)招商、精準招商"培訓(xùn)
中投顧問項目組赴安慶迎江經(jīng)開區(qū)調(diào)研
湖州市吳興區(qū)駐深辦來訪中投顧問
河北邢臺南宮市駐深領(lǐng)導(dǎo)赴中投顧問拜訪
中投顧問陪同廣州某經(jīng)開區(qū)領(lǐng)導(dǎo)赴外商協(xié)會治談合作
